Quantcast

FDA Approves SALMONELEX(TM) Against Salmonella as New Food Processing Aid

December 30, 2013

WAGENINGEN, The Netherlands, December 30, 2013 /PRNewswire/ –

FDA & USDA announced today they have approved SALMONELEX as a “GRAS” (Generally
Recognized as Safe) food processing aid against Salmonella. The new product consists of
natural phages against Salmonella and is produced by Micreos of The Netherlands. The
company confirms that industrial scale projects with US poultry processors will start in
January 2014.

According to a report published in December 2013 by the US Food Safety & Inspection
Services of the USDA, Salmonella contributes most to the FSIS’s ‘All-Illness’ performance
measure and Salmonella illness estimates have continued at a steady high or slightly
increased rate despite FSIS interventions.

Each year, millions of people in the US become sick from foodborne infections. Large
Salmonella outbreaks in 2013 have caused public concern. Caroline Smith DeWaal, food
safety director of the Center for Science in the Public Interest in Washington: “In this
year’s Salmonella outbreak at Foster Farms, thirteen percent of those sickened have
Salmonella septicemia, a serious, life-threatening whole-body inflammation. The Salmonella
strains are showing resistance to multiple antibiotics, and that means more people are
going to the hospital and their infections will be harder for physicians to treat,”

Micreos’ CEO Mark Offerhaus: “Now that the FDA and USDA have given the green light we
can offer food processors a new and natural solution against Salmonella, including
antibiotic resistant strains. SALMONELEX is seen as a very elegant solution as it targets
only Salmonella and has no other effect on the treated food product, neither in taste, nor
texture. Following the successful launch of LISTEX against Listeria, we are now further
expanding the ‘green’ arsenal of weapons against foodborne pathogens. Given the prevalence
of Salmonella in raw poultry, we expect poultry processors to be the first and largest
users of SALMONELEX”.

SALMONELEX eliminates Salmonella, rather than merely inhibiting its growth. It is easy
to apply: it can be sprayed topically or added to chill tank water. Micreos anticipates
that it will soon be listed by the Organic Material Review Institute (OMRI) for use in
organic foods, just like its phage product against Listeria, LISTEX.

Dirk de Meester, business development manager for Micreos: “Research has shown that
SALMONELEX does not dissipate in the presence of protein. Thus, the product enables
processors to reduce the use of chemicals and reach Salmonella in places where
antimicrobial chemicals are ineffective, for example in follicles which close when exposed
to cold water in a chiller.”

# # #

MICREOS (http://www.micreos.com), located in Wageningen (“Food Valley”), The
Netherlands, develops phage products against unwanted bacteria and is considered a leader
in this field. Micreos Food Safety collaborates with many independent partners and
institutes, including the Swiss Federal Technology Institute Zurich, (ETH), Mississippi
State University, Danish Meat Research Institute, NIZO Food Research of The Netherlands
and Nofima of Norway. Micreos Human Health has developed Gladskin (
http://www.gladskin.com) for people with skin conditions caused or aggravated by
certain bacteria, such as acne, eczema and rosacea.

http://www.micreos.com

http://www.micreosfoodsafety.com

SOURCE Micreos


Source: PR Newswire



comments powered by Disqus